Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare Study

Area of Science:

• Microbiology
• Oncology
• Gastroenterology

Background:

• Cachexia contributes to 20% of cancer deaths and indicates a poor prognosis.
• Fusobacterium nucleatum (Fn) is a known risk factor for colorectal cancer (CRC).
• The relationship between Fn and cachexia in CRC patients remains unestablished.

Purpose of the Study:

• To investigate the association between Fn abundance in pre-surgical stool samples and the development of cachexia in CRC patients.
• To explore potential microbial factors influencing cancer cachexia.

Main Methods:

• A cohort of 87 patients with stages I-III CRC was studied.
• Pre-surgical stool samples were analyzed for Fn abundance.
• Cachexia onset was assessed at 6 months post-surgery.

Main Results:

• High fecal Fn abundance was significantly associated with an increased risk of cachexia onset (OR=4.82, p=0.03).
• Patients with high Fn levels had a 4-fold higher risk of developing cachexia 6 months after surgery.

Conclusions:

• High fecal Fn abundance may be a risk factor for developing cachexia in CRC patients.
• This study provides novel insights into the potential mechanisms linking gut microbiota and cancer cachexia.
• Larger studies are needed to validate these preliminary findings and explore clinical implications.